Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

The generation of chromosomal deletions to provide extensive coverage and subdivision of the Drosophila melanogaster genome.

Cook RK, Christensen SJ, Deal JA, Coburn RA, Deal ME, Gresens JM, Kaufman TC, Cook KR.

Genome Biol. 2012;13(3):R21. doi: 10.1186/gb-2012-13-3-r21.

PMID:
22445104
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.

Zhou XF, Shao Q, Coburn RA, Morris ME.

Pharm Res. 2005 Dec;22(12):1989-96. Epub 2005 Sep 20.

PMID:
16158213
[PubMed - indexed for MEDLINE]
3.

Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1.

Zhou XF, Coburn RA, Morris ME.

J Pharm Sci. 2005 Oct;94(10):2256-65.

PMID:
16136554
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics and bioavailability of a newly synthesized dihydropyridine compound with multidrug resistance reversal activity.

Zhou XF, Macdiarmid J, Coburn RA, Morris ME.

Biopharm Drug Dispos. 2005 Oct;26(7):279-85.

PMID:
15991253
[PubMed - indexed for MEDLINE]
5.

Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.

Zhang S, Yang X, Coburn RA, Morris ME.

Biochem Pharmacol. 2005 Aug 15;70(4):627-39.

PMID:
15979586
[PubMed - indexed for MEDLINE]
6.

A high-performance liquid chromatographic method for determination of the niguldipine analogue DHP-014.

Zhou XF, Wang Q, Coburn RA, Morris ME.

Biomed Chromatogr. 2006 Jan;20(1):48-53.

PMID:
15954160
[PubMed - indexed for MEDLINE]
7.

Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies.

Zhou XF, Yang X, Wang Q, Coburn RA, Morris ME.

Drug Metab Dispos. 2005 Aug;33(8):1220-8. Epub 2005 May 20.

PMID:
15908473
[PubMed - indexed for MEDLINE]
Free Article
8.

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors.

Zhou XF, Zhang L, Tseng E, Scott-Ramsay E, Schentag JJ, Coburn RA, Morris ME.

Drug Metab Dispos. 2005 Mar;33(3):321-8. Epub 2004 Dec 7.

PMID:
15585608
[PubMed - indexed for MEDLINE]
Free Article
9.

QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead.

Mager PP, Coburn RA, Solo AJ, Triggle DJ, Rothe H.

Drug Des Discov. 1992 Jul;8(4):273-89.

PMID:
1445993
[PubMed - indexed for MEDLINE]
10.

1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach.

Coburn RA, Wierzba M, Suto MJ, Solo AJ, Triggle AM, Triggle DJ.

J Med Chem. 1988 Nov;31(11):2103-7.

PMID:
2846838
[PubMed - indexed for MEDLINE]
11.

Structural determinants of activity of chlorhexidine and alkyl bisbiguanides against the human oral flora.

Baker PJ, Coburn RA, Genco RJ, Evans RT.

J Dent Res. 1987 Jun;66(6):1099-106.

PMID:
3476581
[PubMed - indexed for MEDLINE]
12.

Substituted 2-(2-hydroxyphenyl)benzimidazoles as potential agents for the control of periodontal diseases.

Coburn RA, Clark MT, Evans RT, Genco RJ.

J Med Chem. 1987 Jan;30(1):205-8.

PMID:
3806595
[PubMed - indexed for MEDLINE]
13.

5-(Alkylsulfonyl)salicylanilides as potential dental antiplaque agents.

Clark MT, Coburn RA, Evans RT, Genco RJ.

J Med Chem. 1986 Jan;29(1):25-9.

PMID:
3941411
[PubMed - indexed for MEDLINE]
14.

Tetracycline and its derivatives strongly bind to and are released from the tooth surface in active form.

Baker PJ, Evans RT, Coburn RA, Genco RJ.

J Periodontol. 1983 Oct;54(10):580-5.

PMID:
6580410
[PubMed - indexed for MEDLINE]
15.

Synthesis and in vitro antimicrobial activity of 5-substituted 2H-1,3,5-thiadiazine-2,4(3H)-diones.

Coburn RA, Ho C, Bronstein ML.

J Med Chem. 1982 Apr;25(4):481-3.

PMID:
7069727
[PubMed - indexed for MEDLINE]
16.

Preliminary evaluation of mesoionic 6-substituted 1-methylimidazo[2,1-b][1,3]thiazine-5,7-diones as potential novel prodrugs of methimazole.

Coburn RA, Taylor MD, Wright WL.

J Pharm Sci. 1981 Dec;70(12):1322-4.

PMID:
7320844
[PubMed - indexed for MEDLINE]
17.

Potential salicylamide antiplaque agents: in vitro antibacterial activity against Actinomyces viscosus.

Coburn RA, Batista AJ, Evans RT, Genco RJ.

J Med Chem. 1981 Oct;24(10):1245-9.

PMID:
7328586
[PubMed - indexed for MEDLINE]
18.

In vitro testing of plaque control agents.

Coburn RA.

J Dent Res. 1979 Dec;58(12):2396-403.

PMID:
292688
[PubMed - indexed for MEDLINE]
19.

Alkyl-bisbiguanides as in vitro inhibitors of bacterial growth and dental plaque formation.

Baker PJ, Coburn RA, Genco RJ, Evans RT.

J Periodontal Res. 1979 Jul;14(4):352-60. No abstract available.

PMID:
161580
[PubMed - indexed for MEDLINE]
20.

The in vitro inhibition of microbial growth and plaque formation by surfactant drugs.

Baker PJ, Coburn RA, Genco RJ, Evans RT.

J Periodontal Res. 1978 Sep;13(5):474-85.

PMID:
151134
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk